Previous 10 | Next 10 |
Aravive (NASDAQ: ARAV ) +212% on promise of lead candidate . More news on: Aravive, Inc., Cancer Genetics, Inc., My Size, Inc., Stocks on the move, Read more ...
LEXINGTON, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company,”“T2,” or “T2 Biosystems”), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in h...
T2 Biosystems, Inc. (TTOO) Q3 2019 Earnings Conference Call November 12, 2019 8:30 a.m. ET Company Participants Zack Kubow - W2O Group John McDonough - Chairman and CEO John Sprague - CFO Tom Lowery - Chief Scientific Officer Conference Call Participants Puneet Souda - SV...
Solid Biosciences (NASDAQ: SLDB ) -71% on another clinical hold on DMD gene therapy . More news on: Solid Biosciences Inc., Diplomat Pharmacy, Inc., Fluent, Inc., Stocks on the move, Read more ...
T2 Biosystems ( TTOO ) Q3 results : Revenues: $1.6M; Product revenue: $1.4M (+17%); Research and grant contribution revenues: $0.2M. More news on: T2 Biosystems, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
LEXINGTON, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company,”“T2,” or “T2 Biosystems”), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in h...
LEXINGTON, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will be highlighting its portfolio and pipeline of products in a keynote ...
LEXINGTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019 third quarter financial and operational results bef...
The following slide deck was published by T2 Biosystems, Inc. in conjunction with this Read more ...
LEXINGTON, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will showcase its latest rapid diagnostics for the detection of sepsis-ca...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2024 and business updates after mar...
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financia...
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion ...